Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services

Bristol-Myers Squibb Company Announces Voluntary Delisting From NYSE Arca
 
    NEW YORK, Dec. 1 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE:
BMY) today announced that it will voluntarily withdraw its securities from
listing on NYSE Arca, Inc., formerly the Pacific Exchange. Bristol-Myers
Squibb securities will continue to be listed on the New York Stock
Exchange.
    The decision to voluntarily withdraw listing from NYSE Arca, Inc. was
made to eliminate duplicative administrative requirements inherent with
dual listings as a result of the NYSE Group's recent merger with Achipelago
Holdings, the parent company of NYSE Arca. NYSE Arca will continue trading
Bristol-Myers Squibb securities on an unlisted trading privilege basis.
    Bristol-Myers Squibb Company is a global pharmaceutical and related
health care products company whose mission is to extend and enhance human
life.
SOURCE Bristol-Myers Squibb



Back to Topback to top

Related links:
  • http://www.bms.com
    CONTACT:
    Media, Jeff Macdonald, Communications,
    +1-212-546-4824, jeffrey.macdonald@bms.com; or Investors, John
    Elicker, Investor Relations, +1-212-546-3775,
    john.elicker@bms.com
    www.technorati.com Blogs Linking to this News Release at Technorati
    Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
    Terms and conditions, including restrictions on redistribution, apply.
    Copyright © 1996- PR Newswire Association LLC. All Rights Reserved.
    A United Business Media company.